focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.56
Bid: 1.56
Ask: 1.572
Change: 0.006 (0.39%)
Spread: 0.012 (0.769%)
Open: 1.562
High: 1.57
Low: 1.554
Prev. Close: 1.554
CBKD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CIB 1H2021 Condensed Separate Financial Results

13 Jul 2021 07:00

RNS Number : 9927E
Commercial Intnl Bank (Egypt) SAE
13 July 2021
 

 

 

 

 

 Click on, or paste the following link into your web browser, to view the associated PDF document.

 

http://www.rns-pdf.londonstockexchange.com/rns/9927E_1-2021-7-12.pdf

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial International Bank (Egypt) S.A.E.

Separate Financial Statements

June 30, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim Balance Sheet as at June 30,2021

 

 

Notes

Jun. 30, 2021

 

Dec. 31, 2020

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

 

Assets

 

 

 

 

 

Cash and balances at the central bank

7

31,792,597

 

33,572,597

 

Due from banks

8

79,079,990

 

86,997,034

 

Loans and advances to banks, net

10

782,360

 

776,980

 

Loans and advances to customers, net

11

130,469,575

 

118,854,880

 

Derivative financial instruments

 

292,284

 

248,759

 

Investments

 

 

 

 

 

- Financial Assets at Fair Value through P&L

12

208,429

 

359,959

 

- Financial Assets at Fair Value through OCI

12

187,616,393

 

147,646,432

 

- Amortized cost

12

22,369,984

 

25,020,917

 

- Investments in associates and subsidiaries

13

1,022,433

 

874,348

 

Other assets

 

10,930,487

 

9,095,212

 

Deferred tax assets (Liabilities)

 

456,600

 

437,772

 

Property and equipment

14

2,455,283

 

2,259,940

 

Total assets

 

467,476,415

 

426,144,830

 

Liabilities and equity

 

 

 

 

 

Liabilities

 

 

 

 

 

Due to banks

15

1,313,331

 

8,815,561

 

Due to customers

16

384,955,527

 

340,086,524

 

Derivative financial instruments

 

354,701

 

331,073

 

Current tax liabilities

 

1,616,491

 

859,582

 

Other liabilities

 

7,332,878

 

5,679,266

 

Other loans

 

5,626,792

 

7,746,946

 

Provisions

17

3,509,061

 

3,221,252

 

Total liabilities

 

404,708,781

 

366,740,204

 

Equity

 

 

 

 

 

Issued and paid up capital

 

14,776,813

 

14,776,813

 

Reserves

 

40,241,849

 

33,085,554

 

Reserve for employee stock ownership plan (ESOP)

 

1,381,162

 

1,064,648

 

Retained earnings *

 

6,367,810

 

10,477,611

 

Total equity and net profit for the period / year

 

62,767,634

 

59,404,626

 

Total liabilities and equity

 

467,476,415

 

426,144,830

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

 

 

 

 

(Review report attached)

 

 

 

 

*

Including net profit for the current period

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hussein Abaza

Sherif Samy

 

CEO & Managing Director

Chairman

 

 

Condensed Separate Interim Income Statement for the period ended June 30, 2021

 

 

 

 

 

 

 

 

 

Notes

 

Jun. 30, 2021

 

 

Jun. 30, 2020

 

 

 

 

EGP Thousands

 

 

EGP Thousands

 

 

 

 

 

 

 

 

 

Interest and similar income

 

 

20,975,491

 

 

20,922,642

 

Interest and similar expense

 

 

(9,302,462)

 

 

(8,445,745)

 

Net interest income

 

 

11,673,029

 

 

12,476,897

 

 

 

 

 

 

 

 

 

Fee and commission income

 

 

1,798,447

 

 

1,479,217

 

Fee and commission expense

 

 

(687,129)

 

 

(493,057)

 

Net fee and commission income

 

 

1,111,318

 

 

986,160

 

 

 

 

 

 

 

 

 

Dividend income

 

 

63,572

 

 

25,962

 

Net trading income

5

 

274,657

 

 

177,231

 

Profits (Losses) on financial investments

12

 

577,519

 

 

832,005

 

Administrative expenses

 

 

(2,918,943)

 

 

(2,844,898)

 

Other operating (expenses) income

 

 

(1,113,292)

 

 

(1,847,487)

 

Impairment release (charges) for credit losses

 

 

(1,019,076)

 

 

(2,259,654)

 

Profit before income tax

 

 

8,648,784

 

 

7,546,216

 

 

 

 

 

 

 

 

 

Income tax expense

 

 

(2,590,270)

 

 

(2,652,208)

 

Deferred tax assets (Liabilities)

 

 

18,828

 

 

107,601

 

Net profit for the period

 

 

6,077,342

 

 

5,001,609

 

 

 

 

 

 

 

 

 

Earning per share

6

 

 

 

 

 

 

Basic

 

 

3.64

 

 

3.00

 

Diluted

 

 

3.63

 

 

2.99

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hussein Abaza

 

 

 

 

Sherif Samy

 

 

CEO & Managing Director

 

 

 

 

Chairman

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim statement of Comprehensive Income for the period ended June 30, 2021

 

 

 

 

 

 

 

 

 

 

Jun. 30, 2021

 

 

Jun. 30, 2020

 

 

 

EGP Thousands

 

 

EGP Thousands

 

 

 

 

 

 

 

Net profit for the period

 

 

6,077,342

 

 

5,001,609

 

 

 

 

 

 

 

Change in fair value of debt instruments measured at fair value through other comprehensive income

 

 

(1,624,416)

 

 

(1,483,581)

Transferred from reserve on disposal of financial assets at fair value through OCI

 

 

(104,406)

 

 

-

Effect of ECL in fair value of debt instruments measured at fair value through OCI

 

 

(54,113)

 

 

90,512

Total comprehensive income for the period

 

 

4,294,407

 

 

3,608,540

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim Cash flows for the period ended June 30, 2021

 

 

 

 

 

 

Notes

Jun. 30, 2021

Jun. 30, 2020

 

 

 

EGP Thousands

EGP Thousands

 

 

 

 

 

 

Cash flow from operating activities

 

 

 

 

Profit before income tax

 

8,648,784

7,546,216

 

Adjustments to reconcile net profit to net cash provided by operating activities

 

 

 

 

Fixed assets depreciation

14

411,612

328,251

 

Impairment charge for credit losses (Loans and advances to customers and banks)

 

1,060,008

2,144,988

 

Other provisions charges

17

350,323

1,096,888

 

Impairment charge for credit losses (due from banks)

 

13,181

24,154

 

Impairment charge for credit losses (financial investments)

 

(54,113)

90,512

 

Impairment charge for other assets

 

25,524

24,621

 

Exchange revaluation differences for financial assets at fair value through OCI

 

50,039

(85,180)

 

Released (Impairment) charge financial assets at fair value through OCI

 

(72,957)

78,615

 

Exchange differences in financial investments in subsidiary

 

-

(242)

 

Utilization of other provisions

17

(44,173)

(1,066)

 

Other provisions no longer used

17

(9,145)

(43,200)

 

Exchange differences of other provisions

17

(9,196)

3,011

 

(Profits) losses from selling property, plant and equipment

 

(1,250)

(94)

 

(Profits) losses from selling financial investments

12

(514,837)

(924,720)

 

Shares based payments

 

316,514

296,959

 

Released (Impairment) charges of investments in associates and subsidiaries

 

10,275

14,100

 

Operating profits before changes in operating assets and liabilities

 

10,180,589

10,593,813

 

 

 

 

 

 

Net decrease (increase) in assets and liabilities

 

 

 

 

Due from banks

 

(8,642,436)

(507,846)

 

Financial assets at fair value through P&L

12

151,530

61,477

 

Derivative financial instruments

 

(19,897)

(41,469)

 

Loans and advances to banks and customers

10 - 11

(12,680,083)

(2,430,817)

 

Other assets

 

(1,944,779)

925,679

 

Due to banks

15

(7,502,230)

460,488

 

Due to customers

16

44,869,003

14,460,587

 

Income tax obligations paid

 

(973,779)

(4,639,364)

 

Other liabilities

 

794,030

(2,962,457)

 

Net cash used in (generated from) operating activities

 

24,231,948

15,920,091

 

 

 

 

 

 

Cash flow from investing activities

 

 

 

 

Proceeds from investments in associates.

 

-

750

 

Proceeds (payments) for investment in associates.

 

(158,360)

(560,963)

 

Payment for purchases of property, plant, equipment and branches constructions

 

(522,975)

(625,596)

 

Proceeds from selling property, plant and equipment

 

1,250

94

 

Proceeds from redemption of financial assets at amortized cost

 

2,654,583

59,360,102

 

Payment for purchases of financial assets at amortized cost

 

(3,844)

(44,945,839)

 

Payment for purchases of financial assets at fair value through OCI

 

(111,506,191)

(50,506,453)

 

Proceeds from selling financial assets at fair value through OCI

 

71,451,202

55,237,128

 

Net cash generated from (used in) investing activities

 

(38,084,335)

17,959,223

 

 

 

 

 

 

 

 

 

 

 

Cash flow from financing activities

 

 

 

 

Received (Repaid) in long term loans

 

(2,120,154)

(22,492)

 

Dividend paid

 

(1,360,652)

(3,370,464)

 

Net cash generated from (used in) financing activities

 

(3,480,806)

(3,392,956)

 

 

 

 

 

 

 

 

 

 

 

Net (decrease) increase in cash and cash equivalent during the priod

 

(17,333,193)

30,486,358

 

Beginning balance of cash and cash equivalent

 

75,965,247

22,895,017

 

Cash and cash equivalent at the end of the period

 

58,632,054

53,381,375

 

 

 

 

 

 

Cash and cash equivalent comprise:

 

 

 

 

Cash and balances at the central bank

 

31,792,597

30,421,432

 

Due from banks

 

79,116,502

56,818,722

 

Treasury bills and other governmental notes

 

58,677,132

27,424,701

 

Obligatory reserve balance with CBE

 

(26,239,755)

(22,905,156)

 

Due from banks with maturities more than three months

 

(26,293,821)

(10,266,780)

 

Treasury bills with maturity more than three months

 

(58,420,601)

(28,111,544)

 

Total cash and cash equivalent

 

58,632,054

53,381,375

 

 

 

Condensed Separate Interim statement of changes in shareholders' equity for the period ended June 30, 2020

Jun. 30, 2020

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

 

 

 

 

 

 

 

 

 

 

EGP Thousands

Beginning balance

14,690,821

2,188,029

16,474,429

1,549,445

13,466

4,111,781

5,164

11,803,555

963,152

51,799,842

Transferred to reserves

-

590,106

7,840,286

-

1,440

-

-

(8,431,832)

-

-

Dividend paid

-

-

-

-

-

-

-

(3,370,464)

-

(3,370,464)

Net profit for the period

-

-

-

-

-

-

-

5,001,609

-

5,001,609

Transferred from reserve of financial assets at fair value through OCI

-

-

-

-

-

(55,142)

-

55,142

-

-

Net unrealised gain/(loss) on financial assets at fair value through OCI

-

-

-

-

-

(1,483,581)

-

-

-

(1,483,581)

Transferred (from) to bank risk reserve

-

-

-

-

-

-

1,259

(1,259)

-

-

ECL for impairment of debt instruments investments

-

-

-

-

-

90,512

-

-

-

90,512

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

296,959

296,959

Ending balance

14,690,821

2,778,135

24,314,715

1,549,445

14,906

2,663,570

6,423

5,056,751

1,260,111

52,334,877

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim statement of changes in shareholders' equity for the period ended June 30, 2021

 

Jun. 30, 2021

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

 

 

 

 

 

 

 

 

 

 

EGP Thousands

Beginning balance

14,776,813

2,778,135

24,765,658

1,549,445

14,906

3,970,987

6,423

10,477,611

1,064,648

59,404,626

Transferred to reserves

-

514,939

8,420,479

-

1,094

-

-

(8,936,512)

-

-

Dividend paid

-

-

-

-

-

-

-

(1,360,652)

-

(1,360,652)

Net profit for the period

-

-

-

-

-

-

-

6,077,342

-

6,077,342

Transferred from reserve on disposal of financial assets at fair value through OCI

-

-

-

-

-

(104,406)

-

104,406

-

-

Transferred from previous years' outstanding balances

-

-

-

-

-

-

-

8,333

-

8,333

Net unrealised gain/(loss) on financial assets at fair value through OCI

-

-

-

-

-

(1,624,416)

-

-

-

(1,624,416)

Transferred (from) to banking risk reserve

-

-

-

-

-

-

2,718

(2,718)

-

-

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

(54,113)

-

-

-

(54,113)

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

316,514

316,514

Ending balance

14,776,813

3,293,074

33,186,137

1,549,445

16,000

2,188,052

9,141

6,367,810

1,381,162

62,767,634

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR BIGDRBSBDGBD
Date   Source Headline
4th Mar 20227:00 amRNSInvitation toCIB Ordinary General Assembly Meeting
22nd Feb 20227:00 amRNSCIB FY 2021 Separate Financial results
22nd Feb 20227:00 amRNSCIB FY 2021 Consolidated Financial Results
22nd Feb 20227:00 amRNSCIB FY2021 Earnings Release
12th Nov 20217:00 amRNSCIB 3Q21 Separate Condensed Financial Results
12th Nov 20217:00 amRNSCIB 3Q21 Earnings Release
12th Nov 20217:00 amRNSCIB 3Q21 Condensed Consolidated Financial Results
13th Jul 20217:00 amRNSCIB1H2021 Earnings Release
13th Jul 20217:00 amRNSCIB1H2021 Condensed Consolidated Financial Results
13th Jul 20217:00 amRNSCIB 1H2021 Condensed Separate Financial Results
24th Jun 20213:43 pmRNSRelease re the change of title of Mr.Hussein Abaza
24th May 20217:00 amRNSCIB 1Q2021 Earnings Release
24th May 20217:00 amRNSCIB 1st Quarter Consolidated Financial Results
24th May 20217:00 amRNSCIB 1st Quarter Separate Financial Results
29th Apr 202110:09 amRNSCIB FY2020 Annual Financial Report
31st Mar 20215:28 pmRNSResolutions of CIB ordinary GAM held on March 30
8th Mar 20218:24 amRNSInvitation to CIB OrdinaryGeneral Assembly Meeting
8th Mar 20217:00 amRNSRelease regarding a change in CIB's BOD Structure
1st Mar 20217:00 amRNSCIB FY20 Year End Earnings Release
1st Mar 20217:00 amRNSCIB FY20 Year End Separate Financial Results
1st Mar 20217:00 amRNSCIB FY20 Consolidated Results
16th Dec 20207:00 amRNSCIB 3Q20 Earnings Release
16th Dec 20207:00 amRNSCIB 3rd Quarter Consolidated Condensed Results
16th Dec 20207:00 amRNSCIB 3rd Quarter Separate Condensed Results
16th Nov 20207:00 amRNSCIB Release on November 15th,2020
27th Oct 20202:28 pmRNSCIB's Press Release dated October 27th, 2020
23rd Oct 20203:59 pmRNSCIB Press Release
12th Oct 20204:13 pmRNSRelease concerning changes in CIB'sBoard Structure
22nd Sep 20202:33 pmRNSRelease on change in Board of Directors Structure
15th Sep 20204:35 pmRNSPrice Monitoring Extension
14th Jul 20207:00 amRNSCIB First Half 2020 Earnings Release
14th Jul 20207:00 amRNSCIB Consolidated Interim Condensed June Statements
14th Jul 20207:00 amRNSCIB Interim Separate Condensed June Statements
1st Jul 20201:04 pmRNSRelease on Subordinated debt from CDC
5th May 20207:00 amRNSCIB reports 1Q20 Earning Release
5th May 20207:00 amRNSCIB 1st Quarter Consolidated Results
5th May 20207:00 amRNSCIB 1st Quarter Separate Results
28th Apr 20207:00 amRNSCIB Year End 2019 IFRS Consolidated Results
27th Apr 20207:00 amRNSCIB acquires 51% of Mayfair Bank in Kenya
30th Mar 20209:00 amRNSRelease on CEO self-quarantine
24th Mar 202012:02 pmRNSPrice Monitoring Extension
16th Mar 20207:00 amRNSCIB's AGM Resolutions (March 15th 2020)
16th Mar 20207:00 amRNSCIB's EGM Resolutions (March 15th 2020)
20th Feb 20202:39 pmRNSItems to be discussed in EGM of March 15th, 2020
20th Feb 20202:37 pmRNSItems to be discussed in AGM of March 15th, 2020
18th Feb 20202:31 pmRNSInvitation to CIB Extraordinary GAM
18th Feb 20202:29 pmRNSInvitation toCIB Ordinary General Assembly Meeting
4th Feb 20207:00 amRNSFY 2019 Separate Financial Results
4th Feb 20207:00 amRNSFY 2019 Consolidated Financial Results
4th Feb 20207:00 amRNSFY 2019 Earnings Release

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.